Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Aclarion, Inc.ACON · Entity 8157 | Chief Financial Officer | December 29, 2022 | December 29, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Aclarion, Inc.
Report date December 29, 2022 · Filed December 29, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,100 |
Reported balance
After 2022-12-29 transaction · row 1
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 1 · 2022-12-29 · Purchase · Acquired 4,100 · Balance 4,100 F1: The Reporting Person purchased common stock on the public market on 12/29/2022. |
| Common StockSEC Table I · non-derivative | Direct | 22,404.411 |
Reported balance
After 2022-12-29 transaction · row 2
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 2 · 2022-12-29 · Purchase · Acquired 18,304.441 · Balance 22,404.411 F1: The Reporting Person purchased common stock on the public market on 12/29/2022. |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting Person purchased common stock on the public market on 12/29/2022.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 29, 2022 Filed Dec 29, 2022 18:27 UTC | Aclarion, Inc. ACON · Entity 8157 | PurchaseCommon Stock | 18,304.441 | $0.45 | $8,237.00 |
DisclosureSEC source: 0001683168-22-008686 · ownership.xml · nonDerivative · entry 2 Lorbiecki John Paul · CIK 0001900821 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,404.411 F1 · shares: The Reporting Person purchased common stock on the public market on 12/29/2022. Read SEC document |
| December 29, 2022 Filed Dec 29, 2022 18:27 UTC | Aclarion, Inc. ACON · Entity 8157 | PurchaseCommon Stock | 4,100 | $0.43 | $1,763.00 |
DisclosureSEC source: 0001683168-22-008686 · ownership.xml · nonDerivative · entry 1 Lorbiecki John Paul · CIK 0001900821 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,100 F1 · shares: The Reporting Person purchased common stock on the public market on 12/29/2022. Read SEC document |
| September 15, 2022 Filed Sep 15, 2022 17:10 UTC | Aclarion, Inc. ACON · Entity 8157 | GrantOptions for Common Stock (right to buy) · Derivative | 16,455 | $0.00 Strike: $1.94 | $0.00 |
DisclosureSEC source: 0001683168-22-006429 · ownership.xml · derivative · entry 1 Lorbiecki John Paul · CIK 0001900821 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,389 Underlying: Common Stock · 16,455 shares Expires 2031-09-27 F1 · derivative.exercise_date: The shares underlying this option grant will vest in 48 equal monthly installments succeeding the vesting commencement date of October 1, 2021. F2 · balance_after: In accordance with the reporting person's employment agreement, on September 27, 2021 the reporting person was previously granted 66,934 options with substantially identical terms to the newly granted options reported herein. The options reported herein were granted in order to satisfy the equity grant target set forth in the reporting person's employment agreement. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.